Inventor · disambiguated record
Sabrina Pengam
Also filed as: PENGAM SABRINA
7 granted patents·5 pending applications·5 citations·filing 2017–2025
74Inventor score
Files withOSE IMMUNOTHERAPEUTICS12
Top patents by PatentIndex Score
12 records- 0187US11279766B2Anti-SIRPa antibodies and their therapeutic applicationsOSE IMMUNOTHERAPEUTICS·Filed 2017·Granted Mar 22, 2022·3 cites·47 claims
- 0281US11352430B2Humanized anti-human-PD-1 antibody and its use in cancer treatmentOSE IMMUNOTHERAPEUTICS·Filed 2019·Granted Jun 7, 2022·2 cites·15 claims
- 0376US12252546B2Anti-SIRPa antibodies and their therapeutic applicationsOSE IMMUNOTHERAPEUTICS·Filed 2022·Granted Mar 18, 2025·0 cites·23 claims
- 0474US2025215108A1ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONSOSE IMMUNOTHERAPEUTICS·Filed 2025·Application pending·0 cites
- 0570US12331118B2Humanized anti-human-PD-1 antibody and methods of using them for cancer treatmentOSE IMMUNOTHERAPEUTICS·Filed 2022·Granted Jun 17, 2025·0 cites·9 claims
- 0669US12331115B2Uses of anti-SIRPg antibodiesOSE IMMUNOTHERAPEUTICS·Filed 2022·Granted Jun 17, 2025·0 cites·3 claims
- 0757US2023227565A1Method for Treating CD127-Positive Cancers by Administering an Anti-CD127 AgentOSE IMMUNOTHERAPEUTICS·Filed 2022·Application pending·0 cites
- 0855US12448454B2Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereofOSE IMMUNOTHERAPEUTICS·Filed 2022·Granted Oct 21, 2025·0 cites·18 claims
- 0950US2023331852A1Anti-clec-1a antibodies and antigen-binding fragment thereofOSE IMMUNOTHERAPEUTICS·Filed 2020·Application pending·0 cites
- 1049US2022389104A1Method for Treating CD127-Positive Cancers by Administering an Anti-CD127 AgentOSE IMMUNOTHERAPEUTICS·Filed 2021·Application pending·0 cites
- 1147US11884723B2Use of anti-human SIRPa v1 antibodies and method for producing anti-SIRPa v1 antibodiesOSE IMMUNOTHERAPEUTICS·Filed 2019·Granted Jan 30, 2024·0 cites·20 claims
- 1247US2019382483A1NEW USES OF ANTI-SIRPg ANTIBODIESOSE IMMUNOTHERAPEUTICS·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →